The scientist’s investigation covers issues in Cardiology, Internal medicine, Fractional flow reserve, Coronary artery disease and Angioplasty. As part of one scientific family, he deals mainly with the area of Cardiology, narrowing it down to issues related to the Surgery, and often Blood pressure. His study in Artery, Revascularization, Stent, Angina and Hazard ratio are all subfields of Internal medicine.
Bernard De Bruyne interconnects Hemodynamics, Predictive value of tests and Blood flow, Coronary flow reserve in the investigation of issues within Fractional flow reserve. The concepts of his Coronary artery disease study are interwoven with issues in Mace, Coronary arteries, Angiography, Radiology and Lumen. His Angioplasty research is multidisciplinary, incorporating elements of Cardiac catheterization, Balloon, Stress testing, Coronary circulation and Pulmonary wedge pressure.
His primary areas of investigation include Internal medicine, Cardiology, Fractional flow reserve, Coronary artery disease and Percutaneous coronary intervention. Bernard De Bruyne studied Internal medicine and Surgery that intersect with Everolimus. The study incorporates disciplines such as Angiography and Radiology in addition to Cardiology.
His Fractional flow reserve research includes elements of Hemodynamics, Coronary flow reserve and Cardiac catheterization. The Coronary artery disease study combines topics in areas such as Chest pain and Angina. His Percutaneous coronary intervention study integrates concerns from other disciplines, such as Clopidogrel and Clinical endpoint, Randomized controlled trial.
Internal medicine, Cardiology, Fractional flow reserve, Coronary artery disease and Myocardial infarction are his primary areas of study. Bernard De Bruyne integrates Internal medicine with In patient in his research. Percutaneous coronary intervention, Stenosis, Conventional PCI, Revascularization and Artery are the core of his Cardiology study.
His work carried out in the field of Fractional flow reserve brings together such families of science as Hemodynamics, Prospective cohort study, Angiography and Lesion. His Coronary artery disease research focuses on Radiology and how it connects with Coronary computed tomography angiography. His work in Myocardial infarction addresses issues such as Hazard ratio, which are connected to fields such as Proportional hazards model and Computed tomography angiography.
Bernard De Bruyne mainly focuses on Internal medicine, Cardiology, Fractional flow reserve, Coronary artery disease and Myocardial infarction. His study in Internal medicine focuses on Percutaneous coronary intervention, Revascularization, Acute coronary syndrome, Clinical endpoint and Coronary circulation. His research investigates the connection between Cardiology and topics such as Interquartile range that intersect with problems in Coronary atherosclerosis and Odds ratio.
Bernard De Bruyne combines subjects such as Predictive value of tests, Angiography, Stenosis, Severity of illness and Right coronary artery with his study of Fractional flow reserve. His research integrates issues of Coronary angiography, Coronary stenosis and Radiology in his study of Coronary artery disease. The various areas that he examines in his Myocardial infarction study include Randomized controlled trial and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention
Bernard De Bruyne;Uwe Siebert;Fumiaki Ikeno;Volker Klauss.
The New England Journal of Medicine (2009)
A Prospective Natural-History Study of Coronary Atherosclerosis
Gregg W. Stone;Akiko Maehara;Alexandra J. Lansky;Bernard de Bruyne.
The New England Journal of Medicine (2011)
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease
Bernard De Bruyne;Bindu Kalesan;Emanuele Barbato;Zsolt Piroth.
The New England Journal of Medicine (2012)
Percutaneous Coronary Intervention of Functionally Nonsignificant Stenosis: 5-Year Follow-Up of the DEFER Study
Nico H.J. Pijls;Pepijn van Schaardenburgh;Ganesh Manoharan;Eric Boersma.
Journal of the American College of Cardiology (2007)
Fractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: 2-Year Follow-Up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study
Nico H.J. Pijls;William F. Fearon;Pim A.L. Tonino;Uwe Siebert;Uwe Siebert.
Journal of the American College of Cardiology (2010)
Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps).
Bjarne L Nørgaard;Jonathon Leipsic;Sara Gaur;Sujith Seneviratne.
Journal of the American College of Cardiology (2014)
Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation
Pim A.L. Tonino;William F. Fearon;Bernard De Bruyne;Keith G. Oldroyd.
Journal of the American College of Cardiology (2010)
Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis A Randomized Trial
G. Jan Willem Bech;Bernard De Bruyne;Nico H.J. Pijls;Ebo D. de Muinck.
Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial
Raimund Erbel;Carlo Di Mario;Jozef Bartunek;Johann Bonnier.
The Lancet (2007)
Fractional Flow Reserve–Guided PCI for Stable Coronary Artery Disease
Bernard De Bruyne;William F. Fearon;Nico H.J. Pijls;Emanuele Barbato.
The New England Journal of Medicine (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: